Tivorbex
Product Images NDC 42211-202
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tivorbex (NDC 42211-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Iroko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Average Pain Intensity Over 48 Hours For Tivorbex And Placebo Groups – Study 1 (Tivorbex 02)
Figure 2 Average Pain Intensity Over 48 Hours For Tivorbex And Placebo Groups – Study 2 (Tivorbex 03)
Principal Display Panelndc 42211-201-29tivorbex(indomethacin) Capsules20 mgper Capsule90 Capsulesrx Only (Tivorbex 04)
Principal Display Panelndc 42211-202-29tivorbex(indomethacin) Capsules40 mgper Capsule90 Capsulesrx Only (Tivorbex 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.